AUS
NZ
UK
CA
USA
IND
Highlights
- Swiss National Bank its position in Artivion, Inc.
- Multiple asset managers changed their positions in AORT during the first quarter.
- Executive transactions impacted share distribution.
Artivion, Inc. operates in the healthcare sector, focusing on innovative solutions in cardiovascular and vascular tissue technologies. The company is listed on the NYSE Composite, reflecting its public trading status and sector relevance. Recent updates reveal changes by major financial institutions and leadership, indicating a dynamic movement in stock allocation.
Swiss National Bank decreased its position in Artivion (NYSE:AORT) during the first quarter, transferring a portion of its shares. The bank retains a stake in AORT while adjusting its portfolio allocation. Other significant entities altered their positions during the same period. Charles Schwab Management Inc. expanded its reflecting adjustments in its portfolio. Natixis Advisors LLC increased its position, while Thornburg Management Inc. initiated a new stake in Artivion. Zurcher Kantonalbank Zurich Cantonalbank and MCF Advisors LLC also modified their allocations, reflecting activity across various institutions. Overall, a majority of Artivion shares remain under institutional management.
Executive Transactions
Changes in share distribution also occurred among corporate executives. James P. Mackin completed a transaction involving a portion of shares, modifying his ownership stake. Senior vice president Marshall S. Stanton also adjusted his reflecting leadership activity in AORT shares. In total, executive transactions contributed to a notable change in stock distribution among top management.
Updates
Several equities research entities updated their price frameworks for Artivion. Needham & Company LLC raised its price level, signaling an updated evaluation of AORT. Oppenheimer maintained its performance stance, while Canaccord Genuity Group, JMP Securities, and LADENBURG THALM/SH SH issued adjustments reflecting new assessments. These updates provide a refreshed market perspective on the stock, contributing to trading and valuation considerations.
Frequently Asked Questions
- What recent changes occurred in Artivion’s institutional?
Several financial firms altered their positions, with some increasing and others decreasing shares in AORT. - Did any company executives adjust their shares recently?
Yes, both the senior vice president completed share transactions that affected their ownership. - Have there been updates from price evaluation firms?
Yes, multiple research entities updated their assessments, reflecting changes in perspectives for AORT.
